Biotech/ Life Sciences CEO, Investor
CEO, AdimaBio (Clinical Stage, Sickle cell program)
Led as CEO, EpiDestiny-Novo Nordisk, $400MM R&D Collaboration
Biopharma Executive (15+ years)
Connect via LinkedIn at
https://www.LinkedIn.com/in/Santhosh vadivelu/
Invited by: Beatrice Lalanne
if the data has not been changed, no new rows will appear.
| Day | Followers | Gain | % Gain |
|---|---|---|---|
| March 18, 2024 | 20 | +1 | +5.3% |
| April 10, 2023 | 19 | +1 | +5.6% |
| August 18, 2022 | 18 | +1 | +5.9% |
| April 29, 2022 | 17 | +1 | +6.3% |
| January 23, 2022 | 16 | +1 | +6.7% |
| December 16, 2021 | 15 | +1 | +7.2% |
| August 14, 2021 | 14 | +2 | +16.7% |